Acute Ischemic Stroke (AIS) is a leading cause of Death and Disability worldwide.
Up to 30% of AIS patients die within first 30 days...
... and up to 40% die in first 90 days.
Remaining 60% live with severe disability.

CENTRIVIVE significantly Increases Neovascularisation (new blood vessel formation) in ischemic brain and helps expand capillary density to save lives as early as 14 days!

CENTRIVIVE exhibits multi-prong actions

1

CENTRIVIVE helps reconstruct vasculature both existing and new and thus restores blood supply to ischemic brain tissues.

CENTRIVIVE prevents re-stenosis by exhibiting anti-platelet, anti-atherosclerosis & anti-thrombosis actions.

CENTRIVIVE protects mitochondria and improves brain cell viability.

CENTRIVIVE is shown to reduce cerebral edema and protect BBB integrity.